STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

DMAC DIAMEDICA INCORPORATED StockScouter® Report

7

StockScouter® Score

DIAMEDICA INCORPORATED, a small cap company in the healthcare sector, is expected to slightly outperform the market over the next six months with average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • Shares are under accumulation by financial institutions. Marginally positive for a small company like DMAC
  • The most recent quarterly earnings report was approximately equal to or higher than analysts’ consensus forecast, but is not suggestive of future returns. Neutral

 

Concerns

  • Earnings growth in the past year has decelerated rapidly compared to earnings growth in the past three years. Negative
  • One or more analysts has modestly decreased quarterly earnings estimates for DMAC. Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that small cap stocks will be neutral, stocks will be , and healthcare stocks will be neutral.

Expected Risk/Return

Progress: 60% done.
Progress: 80% done.
Low
High

Core Model Grades

C
C
N/A
C

Previous Ratings

7
5
7